Acutus Medical Full Year 2023 Earnings US0.41 loss per share

AFIBDelisted Stock  USD 0.73  0.03  3.95%   
About 61% of Acutus Medical's investor base is looking to short. The analysis of overall sentiment of trading Acutus Medical stock suggests that many investors are alarmed at this time. The current market sentiment, together with Acutus Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Acutus Medical stock news signals to limit their universe of possible portfolio assets.
  
Acutus Medical Full Year 2023 Results Key Financial Results Revenue US7.16m down 56 percent from FY 2022...

Read at finance.yahoo.com
Yahoo News
  

Acutus Medical Fundamental Analysis

We analyze Acutus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acutus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acutus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Acutus Medical is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Acutus Medical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acutus Medical stock to make a market-neutral strategy. Peer analysis of Acutus Medical could also be used in its relative valuation, which is a method of valuing Acutus Medical by comparing valuation metrics with similar companies.

Peers

Acutus Medical Related Equities

AIMDAinos   4.44   
0%
82.0%
CVRXCVRx   3.20   
0%
59.0%
LNSRLENSAR   1.85   
0%
34.0%
AORTArtivion   0.95   
0%
17.0%
ANIKAnika Therapeutics   0.62   
0%
11.0%
OFIXOrthofix Medical   0.06   
0%
1.0%
SSKNSTRATA Skin   0.35   
6.0%
0%
DCTHDelcath Systems   2.01   
37.0%
0%
ATECAlphatec Holdings   2.46   
45.0%
0%
NPCENeuropace   2.62   
48.0%
0%
AXDXAccelerate Diagnostics   5.17   
95.0%
0%
AXGNAxogen   5.41   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Acutus Stock

If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals